|
|
|
Submitting
a Late-Breaker Abstract—Click
here
The Program Committee is committed to
presenting the broadest possible range of high quality work from
the membership at the 2002 PAS Annual Meeting. We would like
both the absolute number of abstracts presented, and the
percentage accepted, to grow. To achieve these goals while
preserving the quality of the Meeting, we ask members sponsoring
each abstract to pay close attention to the abstract content.
Historically, abstracts accepted for presentation are
hypothesis-driven new work. Abstracts rarely accepted for
presentation include single case reports, open label drug
trials, highly speculative accounts of clinical experience, and
op-ed accounts of personal experience. Interim results from an
ongoing clinical trial will not be accepted for presentation
unless the study has been prematurely closed for efficacy, lack
of efficacy, or issues of safety. The submission of multiple,
similar abstracts from the same investigator(s) or laboratory
are strongly discouraged.
The member sponsoring each abstract is the
first and most important part of the review and selection
process. Please contribute to the Meeting quality and do not
sponsor an abstract you would not like to see on the program.
ABSTRACT SELECTION PROCESS
Abstracts of superior quality will be selected by
the PAS Program Committee for presentation at the Meeting in
Baltimore, Maryland. Abstracts will be graded based on quality,
scientific merit/importance, and quality of research, design and
data analysis and the quality of presentation. The submission of
abstracts without data because investigations or analyses are
incomplete will be evaluated only on the basis of the
information contained in the abstract.
Designation of a Theme Choice and the listing
of key words are essential for the program committee to
determine/select abstracts that can be grouped for presentation
in poster symposia and other thematic sessions. Choice of
abstracts for these thematic sessions is the very first step in
the development of the program, and these sessions often include
the most highly rated abstracts. Therefore, it is in your
interest to designate a theme whenever possible. Key words will
be used as the second step in development of the program to
encourage groups of abstracts for presentation among those
authors with similar scientific or clinical interests,
regardless of subspecialty. Subspecialty topic designation will
be the last criterion used in the program development.
AWARD CONSIDERATION AND
SELECTION
The American Pediatric Society, Society for
Pediatric Research, Ambulatory Pediatric Association, and
American Society of Pediatric Hematology/Oncology seek
nominations for awards through the abstract submission process.
Information regarding the awards for 2002, their eligibility
criteria, and the award process can be in the Awards
section.
Please review these criteria and apply for any
award for which you believe you are eligible and would like to
be considered. Only abstracts accepted for presentation are
considered for awards.
Application for an award involves submitting
an abstract, checking the appropriate box in the
"Questionnaire" part of the submission program,
completing the Award Application Form for the respective award,
and including the required supplemental materials (as indicated
in the award information and on the Application Form).
While you are welcome to apply for more than
one award, an Award Application Form is required for EACH award
for which you have indicated an interest (by checking the box in
the "Questionnaire").
TRAVEL GRANTS **NEW FOR
2002**
The Society for Pediatric Research and
American Pediatric Society will award travel grants in the
amount of $500 plus complimentary meeting registration to attend
the PAS Annual Meeting. Travel grants are possible to at
least four runner-ups among the House Officer and Fellow
Basic and Clinical Award categories. Travel grants will be
awarded during the SPR Presidential Plenary Session in
Baltimore, Maryland.
PRESENTATION FORMATS
The Program Committee determines the
appropriate format for presentation (platform, poster, or poster
symposium). Platform sessions will be 2 hours and will consist
of 15-minute presentations (10 minutes for the presentation; 5
minutes for discussion). Poster symposia will be 2 hours and
include both a poster with a viewing period and a formal
presentation or discussion period. The session moderators
determine formats for formal presentation or discussion. Poster
sessions will be 2-3 hours. Detailed instructions for the
preparation of slides and posters as well as scheduling notices
will be mailed to the contact person in advance of the Meeting.
Platform, poster symposia, and poster guidelines will also be
available on the official PAS meeting website (www.pas-meeting.org).
The complete schedule of all abstract presentations will be
finalized by mid February 2002.
PUBLICATION OF ABSTRACTS
ALL abstracts submitted for consideration
to the PAS Annual Meeting will be published in the 2002 Pediatric
Research - Program/Proceedings (April issue) regardless of
presentation status. The journal will be issued to Pediatric
Research subscribers. Other registrants can purchase the
proceedings through registration for the PAS Annual Meeting.
Hematology/Oncology Abstracts: All
abstracts submitted to the Hematology/Oncology subspecialty for
consideration by the program committee will be published in the
2002 March/April issue of the Journal of Pediatric
Hematology/Oncology, regardless of presentation status. The
journal is sent to the Journal of Pediatric
Hematology/Oncology subscribers and to members of the
American Society of Pediatric Hematology/Oncology (ASPH/O). All
registrants for the ASPH/O meeting will receive a copy of the
abstract issue of the Journal of Pediatric
Hematology/Oncology as part of their registration materials.
Deadline for receipt of all
abstract submissions is
December 6, 2001, 11:59 PM CST.
The deadline for submission of
abstracts is absolute. Late submissions will not be
accepted for consideration in regular program planning.
The signed copy, payment, and other supplemental
materials must be received by December 10, 2001.
|
GENERAL POLICIES
- Electronic Submission Deadline is December
6, 2001, 11:59 PM CST.
- A fee of $40.00 is required for each
abstract submitted.
- Only abstracts submitted using the
OFFICIAL electronic submission program or on OFFICIAL 2002
PAS abstract forms will be accepted.
- All abstracts should be submitted in a
structured format.
- All abstracts must be sponsored (and
signed) by a member of one of the sponsoring organizations
for the 2002 Meeting (APS, SPR, or APA) and submitted using
the 2002 OFFICIAL electronic submission program or 2002
OFFICIAL abstract form. The sponsoring member must be in
good standing (dues current) or the abstract will not be
considered. The sponsor does not have to be an author.
- There is no limit on the number of
abstracts submitted by each member or sponsor, but the
submission of multiple, similar abstracts from the same
investigator(s) or laboratory is strongly discouraged.
-
Of Special note: Members of
The American Society of Pediatric Hematology/Oncology (ASPH/O)
may sponsor abstracts when submitted to the
Hematology/Oncology subspecialty.
-
Abstracts submitted or presented to other
societies or national meetings can be submitted for
consideration for the 2002 PAS Meeting.
- Research published in manuscript
form prior to the submission of the abstract is not
appropriate and should not be submitted. If data contained
in the abstract is published after submission of the
abstract, the Central Office must be notified regardless of
timing as soon as publication is recognized. At that time a
member of the program committee will make a determination
concerning presentation.
- Conflict of Interest/Disclosure: Work
submitted for presentation must include an acknowledgment of
funding sources of commercial nature and/or consulting or
holding of significant equity in a company that could be
affected by the results of the study. The intent of this
policy is not to prevent a speaker with a potential conflict
of interest from making a presentation. It is merely
intended that any potential conflict should be identified
openly so that the listeners may form their own judgments
about the presentation with the full disclosure of the
facts. Even if indicated elsewhere in the abstract, this
must appear as the last sentence of the abstract and read
"funded by..." and/or "equity in..." if
pertinent. (See Step 4 - Disclosure Info.)
- The first author must sign the
abstract and attest that all authors have approved the
submission of the work for presentation.
- Any animal studies must conform with the
"Guiding Principles in the Care and Use of
Animals" of the American Physiological Society and any
human experimentation has been conducted according to a
protocol approved by the institutional committee on ethics
of human investigation. And, if no such committee exists,
that it conforms with the principles of the Declaration of
Helsinki of the World Medical Association (Clinical Research
14:193, 1966).
- If the abstract is selected, the
presentation must include the methods used for study and any
other information relevant to research.
ABSTRACT SUBMISSION FEE
The $40.00 per abstract payment can be made
directly online or by printing a special payment form. The
Official Electronic Printed Abstract and the Payment Form can be
printed and signed after submitting the abstract. The signed
copy, payment and supplemental materials must be received by
December 10, 2001.
NOTIFICATION OF RECEIPT AND
ACCEPTANCE
Notification of receipt will be e-mailed to the
contact author within 2 business days of abstract receipt. NOTE:
It is your responsibility to contact Marathon Multimedia
(contact information below) if you do not receive confirmation
of abstract receipt within 2 business days. They will be able to
confirm receipt of your abstract or will assist you to ensure
that your abstract is received.
Marathon Multimedia
Telephone: (507) 334-5212
Facsimile: (507) 334-0126
Email: support@marathonmultimedia.com
Notification of abstract acceptance status
will be mailed after February 15, 2002. If you have not received
notification by February 22, 2002, please contact the PAS
Program Office at (281) 419-0052 or email (info@pas-meeting.org)
for additional assistance.
IMPORTANT
- Electronic abstracts must be submitted by
December 6, 2001, 11:59 PM, Central Standard Time.
- You must print, and return a copy of the
Official Electronic Abstract Printout and the payment form
(if not paid online) by December 10, 2001.
- The official abstract printout must include
the signature of both the sponsor and first author.
- If you wish the abstract to be considered
for an award, the supplemental materials [including the
Award Application Form(s)] must be submitted with the signed
official printout you send by December 10.
Send to the following address:
PAS Abstracts
c/o Marathon Multimedia
1201 West Division St.
Faribault, MN 55021
Telephone: (507) 334-5212 Facsimile:
(507) 334-0126
Email: support@marathonmultimedia.com
| Don't Forget to Fax or Send a
Copy of What You Submitted Electronically:
If you submit your file electronically
and are using a credit card for payment, you may fax in
the signed Official Electronic Abstract Printout. If you
fax copies, please test to make sure that your fax
machine is in good working order and can send a legible
copy of your abstract.
This crucial step also assures you we really
have received your electronic submission.
NOTE Regarding Figures: If
your abstract contains a figure, you must send a
clean black and white copy of the figure for inclusion
in the Abstract Book.
|
Submission Mailing
Address, Telephone, Facsimile, and Email:
PAS Abstracts
c/o Marathon Multimedia
1201 West Division St.
Faribault, MN 55021
Telephone: (507) 334-5212
Facsimile: (507) 334-0126
Email: support@marathonmultimedia.com
|